Please login to the form below

Not currently logged in
Email:
Password:

ClinTec International expands into Turkey

CRO says new office will bolster its presence in the Middle East and North Africa

British contract research organisation (CRO) ClinTec International plans to bolster its existing presence in the Middle East and North Africa with a new office in Istanbul.

The company, which already has bases in the region in Cairo, Egypt, Dubai Health Care City, UAE, and Beirut and Lebanon, said its Turkey office would give its global team access to a new patient population.

Founder and CEO Dr Rabinder Buttar said: "The launch of this new office ... reflects the growing significance of Turkey- and the wider MENA region- to the global clinical research market

"We are delighted to be at the forefront of developing expertise in Turkey and the MENA region as a whole."

Established in 1997, ClinTec has had a presence in Africa for over five years and the Middle East for over seven years, and last year commenced operations in Malawi in a move that strengthened its presence in vaccine development.

21st May 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics